Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms
Sanderson, D.R.
Journal of Clinical Psychiatry 57(4): 177
1996
ISSN/ISBN: 0160-6689 PMID: 8601557 Document Number: 468147
Document emailed within 1 workday
Related Documents
Regenthal, R.; Kunstler, U.; Hesse, S.; Sabri, O.; Preiss, R. 2005: D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(8): 370-378Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171
Inada, T. 1996: Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients Nihon Shinkei Seishin Yakurigaku Zasshi 16(5): 181-185
Al-Khodairy, A.T.; Vuagnat, H.; Uebelhart, D. 1999: Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure: a case report American Journal of Physical Medicine and Rehabilitation 78(3): 272-277
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Husag, L.; Wieser, H.G.; Probst, C. 1975: Extrapyramidal symptoms in meningiomas Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 116(2): 257-279
Daric, C.; Dollfus, S.; Mihout, B.; Omnient, Y.; Petit, M. 1993: Fluoxetine and extrapyramidal symptoms. Two case reports L'Encephale 19(1): 61-62
Saha, P.; Verma, A.K.; Saluja, S.; Sharma, S.K. 1990: Extrapyramidal symptoms in varicella zoster infection Journal of the Association of Physicians of India 38(4): 312-313
Zinchenko, A.P.; Sharaia, N.N.; Savchenko, A.V. 1977: Atypical symptoms and their pathogenesis in extrapyramidal tumors Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 77(6): 801-806
Kane, J.M.; Safferman, A.Z.; Pollack, S.; Johns, C.; Szymanski, S.; Kronig, M.; Lieberman, J.A. 1994: Clozapine, negative symptoms, and extrapyramidal side effects Journal of Clinical Psychiatry 55(Suppl): 74-77
Consoloni, E.; Rossi, R.; Ioppoli, C.; Cartei, M.A.; Fonte, F. 1980: Hereditary degenerative spinocerebellar syndrome with extrapyramidal symptoms Rivista di Neurologia 50(4): 221-230
Bettin, S.; Kämpfer, I.; Seese, A.; Schäfer, A.; Reuter, M.; Lössner, J.; Dietrich, J.; Wagner, A.; Knapp, W.H. 1997: Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms Nuklearmedizin. Nuclear Medicine 36(5): 167-172
Jorgensen, H.; Vogt, H. 1977: Familial, idiopathic hypoparathyroidism with intracerebral calcifications and extrapyramidal symptoms Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 97(15): 771-774
Turck, D.; Largilliere, C.; Dupuis, B.; Farriaux, J.P. 1986: Interaction between diazoxide and phenytoin Presse Medicale 15(1): 31
Lackner, T.E. 1991: Interaction of dexamethasone with phenytoin PharmacoTherapy 11(4): 344-347
Kikuchi, A. 2009: An 8-year-old boy presenting with progressive extrapyramidal symptoms during total parenteral nutrition No to Hattatsu 41(5): 325-326
Jann, M.W.; Bean, J.; Fidone, G.S. 1986: Interaction of dietary pudding with phenytoin Pediatrics 78(5): 952-953
Garcin, R.; Raverdy, P.; Delthil, S.; Man, H.X.; Chimenes, H. 1961: On a heredo-familial disease combining cataract, optic atrophy, extrapyramidal symptoms and certain defects of Friedreich's disease. (Its nosological position in relation to the Behr's syndrome, the Marinesco-Sjogren syndrome and Friedreich's disease with ocular symptoms Revue Neurologique (Paris) 104: 373-379
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Grissette, D.E.; Stewart, S.E.; Coker, S.T.; Davidson, P.P.; Williams, B.B. 1980: Biologic interaction of gamma radiation with phenylbutazone, phenytoin, or hydralazine Research Communications in Chemical Pathology and Pharmacology 29(3): 589-597